Cellular Senescence: From Pathogenic Mechanisms To Precision Anti-Aging Interventions
As we age, our bodies undergo many changes, and one key process involved is called cellular senescence. This is when cells stop dividing and enter a state of permanent growth arrest. These “senescent cells” accumulate in tissues over time and are a major contributor to aging and various age-related diseases, such as heart conditions and neurodegenerative disorders.
One of the ways these cells cause problems is by releasing a mix of inflammatory molecules, enzymes, and growth factors, a phenomenon known as the senescence-associated secretory phenotype, or SASP. This “inflammatory soup” can disrupt the normal function of surrounding tissues and promote further aging.
However, recent research reveals a more nuanced picture: not all senescent cells are detrimental. Some actually play crucial roles in beneficial processes like embryonic development, wound healing, and maintaining tissue health. This dual nature presents a challenge for anti-aging strategies.
The exciting new frontier is “precision geroprotection.” This approach aims to develop interventions that can selectively target and eliminate the harmful senescent cell populations while preserving the beneficial ones. Current strategies include “senolytics,” which are drugs designed to specifically kill senescent cells, and “senomorphics,” which aim to suppress the harmful secretions of the SASP. Future advancements, potentially leveraging technologies like single-cell analysis, will help us better understand the different types of senescent cells and develop even more precise therapies to promote healthy aging.
Source: link to paper